• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    Keymed Biosciences Announces 2025 Results, Business Updates

    PR NEWSWIRE

    Keymed Biosciences (02162.HK) Reports Strong Interim 2025 Results

    PR NEWSWIRE

    Keymed Biosciences Announces Latest CM336 Trial Results in NEJM

    PR NEWSWIRE

    Keymed Biosciences Announces Annual Results of 2024

    PR NEWSWIRE

    Keymed Stapokibart Approved For Seasonal Allergic Rhinitis

    PR NEWSWIRE

    Keymed Bio Gets Approval for Stapokibart in Chronic Rhinosinusitis

    PR NEWSWIRE

    Keymed Biosciences Announces Interim Results for First Half of 2024

    PR NEWSWIRE

    Keymed`s Stapokibart Shows Long-Term Efficacy, Safety In Atopic Dermatitis

    PR NEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.